Search

Biological and Medicinal Chemistry

Working Paper

Are Losartan and Imatinib Effective Against SARS-CoV2 Pathogenesis? a Pathophysiologic-Based in Silico Study

Reza Nejat, Ahmad Shahir Sadr

Version 3 posted 04 November 2020

2,050

Downloads

1

Citations

Biological and Medicinal Chemistry

Working Paper

Application of In-Silico Reverse Vaccinology for Designing Multi-Epitope Vaccine Against Coronavirus

Kumar Sharp, Dr. Shubhangi Dange

Version 1 posted 09 June 2020

1,028

Downloads

Biological and Medicinal Chemistry

Working Paper

Repurposing Nonnucleoside Antivirals Against SARS-CoV2 NSP12 (RNA Dependent RNA Polymerase) and Identification of Domain Specific Interactions

Feroza Begum, UPASANA RAY

Version 1 posted 27 July 2020

586

Downloads

Biological and Medicinal Chemistry

Working Paper

ORF10: Molecular Insights into the Contagious Nature of Pandemic Novel Coronavirus 2019-nCoV

Dr. Seema Mishra

Version 3 posted 12 May 2020

1,701

Downloads

2

Citations

Biological and Medicinal Chemistry

Working Paper

SARS-CoV-2 Mutations in Brazil: From Genomics to Clinical Conditions

Luis Timmers, Julia Peixoto, Rodrigo Ducati, Jose Fernando Bachega, Leandro Mattos Pereira, Rafael Andrade Caceres, Fernanda Majolo, Guilherme Liberato Da Silva, Debora Bublitz Anton, Marcia Inês Goettert, Odir Antônio Dellagostin, Joao Henriques, Leder Xavier, Stefan Laufer

Version 1 posted 19 February 2021

701

Downloads

1

Citations

Biological and Medicinal Chemistry

Working Paper

Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19

Sugandh Kumar, Pratima Kumari, Geetanjali Agnihotri, Preethy VijayKumar, Shaheerah Khan, Gulam Hussain Syed, Anshuman Dixit

Version 1 posted 27 May 2020

1,330

Downloads

Biological and Medicinal Chemistry

Working Paper

Exploiting Modeling Studies for Evaluating the Potential Antiviral Activities of some Clinically Approved Drugs and Herbal Materials Against SARS-CoV-2: Towards Hindering the Virus and Blocking the Human Cellular Receptor

Islam Morad, Ali Khalil, Yousra Abdel-Mottaleb, M. S. A. Abdel-Mottaleb

Version 1 posted 08 February 2022

201

Downloads

Biological and Medicinal Chemistry

Working Paper

Simeprevir and Eltrombopag as Potential Inhibitors of SARS-CoV2 Proteases: A Molecular Docking and Virtual Screening Approach to Combat COVID-19

Ananta Swargiary, AKALESH Verma, Manita Daimari, Mritunjoy Kumar Roy

Version 1 posted 21 September 2020

568

Downloads

Biological and Medicinal Chemistry

Working Paper

Not One, But Five: Virtual Screening-Driven Drug Discovery of SARS-CoV2 Enzyme Inhibitors Targeting Viral Attachment, Replication and Post-Translational Infection Mechanisms

Mark Tristan J. Quimque, Kin Israel Notarte, Rey Arturo T. Fernandez, Mark Andrew O. Mendoza, Rhenz Alfred D. Liman, Justin Allen K. Lim, Luis Agustin E. Pilapil, Jehiel Karsten H. Ong, Adriel M. Pastrana, Allan Patrick Macabeo

Version 2 posted 28 April 2020

1,278

Downloads

2

Citations

Biological and Medicinal Chemistry

Working Paper

Biology-directed and in silico-aided design liberates a potent, simplified and ipomoeassin-F-derived Sec61 inhibitor

Sarah O'Keefe, Pratiti Bhadra, Kwabena Duah, Guanghui Zong, Levise Tenay, Lauren Andrews, Hayden Schneider, Ashley Anderson, Zhijian Hu, Hazim Aljewari, Belinda Hall, Rachel Simmonds, Volkhard Helms, Stephen High, Wei Shi

Version 1 posted 04 March 2022

268

Downloads

Refine Search

30 results in SARS-CoV2, main-protease, S1 receptor binding domain, hydroxychloroquine, curcumin, ANCHOR, Molecular docking in Keywords: SARS-CoV2, main-protease, S1 receptor binding domain, hydroxychloroquine, curcumin, ANCHOR, Molecular docking

Are Losartan and Imatinib Effective Against SARS-CoV2 Pathogenesis? a Pathophysiologic-Based in Silico Study

Application of In-Silico Reverse Vaccinology for Designing Multi-Epitope Vaccine Against Coronavirus

Repurposing Nonnucleoside Antivirals Against SARS-CoV2 NSP12 (RNA Dependent RNA Polymerase) and Identification of Domain Specific Interactions

ORF10: Molecular Insights into the Contagious Nature of Pandemic Novel Coronavirus 2019-nCoV

SARS-CoV-2 Mutations in Brazil: From Genomics to Clinical Conditions

Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19

Exploiting Modeling Studies for Evaluating the Potential Antiviral Activities of some Clinically Approved Drugs and Herbal Materials Against SARS-CoV-2: Towards Hindering the Virus and Blocking the Human Cellular Receptor

Simeprevir and Eltrombopag as Potential Inhibitors of SARS-CoV2 Proteases: A Molecular Docking and Virtual Screening Approach to Combat COVID-19

Not One, But Five: Virtual Screening-Driven Drug Discovery of SARS-CoV2 Enzyme Inhibitors Targeting Viral Attachment, Replication and Post-Translational Infection Mechanisms

Biology-directed and in silico-aided design liberates a potent, simplified and ipomoeassin-F-derived Sec61 inhibitor

30 results in Keywords: SARS-CoV2, main-protease, S1 receptor binding domain, hydroxychloroquine, curcumin, ANCHOR, Molecular docking